Bullboard - Stock Discussion Forum AIM ImmunoTech Inc AIM

Healthcare Biotechnology

AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular ribonucleic acid (RNA) molecules, and Alferon N Injection (Interferon alfa). Its lead product is an investigational drug called... see more

Add To Watchlist

NYSEAM:AIM - Post Discussion

AIM ImmunoTech Inc > AIM ImmunoTech Announces Print Publication and Further Posit

View:

Post by whytestocks on Aug 20, 2024 11:15am

AIM ImmunoTech Announces Print Publication and Further Posit

Breaking News: $AIM AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer ResearchData demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through Ampligen Additional commentary published discussing the potential of Ampligen and two other drugs OCALA, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. ...AIM - AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research